Literature DB >> 23519936

Diversity in sequence-dependent control of GRO chemokine mRNA half-life.

Tomasz Herjan1, Michael Novotny, Thomas A Hamilton.   

Abstract

Neutrophil trafficking to sites of injury or infection is regulated, in part, by the closely related GRO family of chemokines (CXCL1, -2, and -3). Expression of the GRO chemokine genes is known to be determined by transcriptional bursts in response to proinflammatory stimulation, but post-transcriptional mechanisms that regulate mRNA half-life are now recognized as important determinants. mRNA half-life is regulated via distinct sequence motifs and sequence-specific, RNA-binding proteins, whose function is subject to regulation by extracellular proinflammatory stimuli. Moreover, such mechanisms exhibit cell-type and stimulus dependency. We now present evidence that in nonmyeloid cells, GRO2 and GRO3 isoforms exhibit at least two patterns of mRNA instability that are distinguished by differential sensitivity to specific mRNA-destabilizing proteins and stimulus-mediated prolongation of mRNA half-life, respectively. Although the 3' UTR regions of GRO2 and GRO3 mRNAs contain multiple AREs, GRO2 has eight AUUUA pentamers, whereas GRO3 has seven. These confer quantitative differences in half-life and show sensitivity for TTP and KSRP but not SF2/ASF. Moreover, these AUUUA determinants do not confer instability that can be modulated in response to IL-1α. In contrast, IL-1α-sensitive instability for GRO2 and GRO3 is conferred by sequences located proximal to the 3' end of the 3'UTR that are independent of the AUUUA sequence motif. These regions are insensitive to TTP and KSRP but show reduced half-life mediated by SF2/ASF. These sequence-linked, post-transcriptional activities provide substantial mechanistic diversity in the control of GRO family chemokine gene expression.

Entities:  

Keywords:  IL-1α; RNA-binding proteins; gene expression; stability

Mesh:

Substances:

Year:  2013        PMID: 23519936      PMCID: PMC3656334          DOI: 10.1189/jlb.0812370

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  43 in total

Review 1.  Chemokines and disease.

Authors:  C Gerard; B J Rollins
Journal:  Nat Immunol       Date:  2001-02       Impact factor: 25.606

2.  Heterogeneity in control of mRNA stability by AU-rich elements.

Authors:  Julie Tebo; Sandy Der; Mathias Frevel; Khalid S A Khabar; Bryan R G Williams; Thomas A Hamilton
Journal:  J Biol Chem       Date:  2003-01-28       Impact factor: 5.157

Review 3.  Points of control in inflammation.

Authors:  Carl Nathan
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

Review 4.  Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.

Authors:  Antal Rot; Ulrich H von Andrian
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

Review 5.  Cell type- and stimulus-specific mechanisms for post-transcriptional control of neutrophil chemokine gene expression.

Authors:  Thomas Hamilton; Xiaoxia Li; Michael Novotny; Paul G Pavicic; Shyamasree Datta; Chenyang Zhao; Justin Hartupee; Dongxu Sun
Journal:  J Leukoc Biol       Date:  2011-12-13       Impact factor: 4.962

6.  Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability.

Authors:  E Carballo; W S Lai; P J Blackshear
Journal:  Blood       Date:  2000-03-15       Impact factor: 22.113

7.  Regulation of chemokine mRNA stability by lipopolysaccharide and IL-10.

Authors:  Roopa Biswas; Shyamasree Datta; Jaydip Das Gupta; Michael Novotny; Julie Tebo; Thomas A Hamilton
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

8.  Distinct temporal patterns of macrophage-inflammatory protein-2 and KC chemokine gene expression in surgical injury.

Authors:  Brian Endlich; David Armstrong; Jason Brodsky; Michael Novotny; Thomas A Hamilton
Journal:  J Immunol       Date:  2002-04-01       Impact factor: 5.422

9.  Differential local and systemic regulation of the murine chemokines KC and MIP2.

Authors:  D R Call; J A Nemzek; S J Ebong; G R Bolgos; D E Newcomb; G K Wollenberg; D G Remick
Journal:  Shock       Date:  2001-04       Impact factor: 3.454

10.  Neutrophil chemoattractant genes KC and MIP-2 are expressed in different cell populations at sites of surgical injury.

Authors:  David A Armstrong; Jennifer A Major; Alison Chudyk; Thomas A Hamilton
Journal:  J Leukoc Biol       Date:  2004-01-02       Impact factor: 4.962

View more
  4 in total

Review 1.  Role of KSRP in control of type I interferon and cytokine expression.

Authors:  Peter H King; Ching-Yi Chen
Journal:  J Interferon Cytokine Res       Date:  2014-04       Impact factor: 2.607

2.  Differential protein occupancy profiling of the mRNA transcriptome.

Authors:  Markus Schueler; Mathias Munschauer; Lea Haarup Gregersen; Ana Finzel; Alexander Loewer; Wei Chen; Markus Landthaler; Christoph Dieterich
Journal:  Genome Biol       Date:  2014-01-13       Impact factor: 13.583

Review 3.  The Potential of Omics Technologies in Lyme Disease Biomarker Discovery and Early Detection.

Authors:  Alaa Badawi
Journal:  Infect Dis Ther       Date:  2016-11-29

Review 4.  CXCL1: Gene, Promoter, Regulation of Expression, mRNA Stability, Regulation of Activity in the Intercellular Space.

Authors:  Jan Korbecki; Katarzyna Barczak; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2022-01-12       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.